Symptoms, Diagnosis, and GI Involvement

Because Mantle Cell Lymphoma (MCL) cells travel through the lymphatic system and the bloodstream, the disease is usually “systemic” or widespread by the time it is discovered. In fact, roughly 70% to 90% of patients have Stage IV disease at the time of diagnosis ^[1][2]. This means the lymphoma is often found in multiple lymph node groups, the spleen, the bone marrow, and the circulating blood ^[1][3]. It is important to remember that Stage IV in lymphoma is very different from Stage IV in solid tumors (like breast or lung cancer)—it is still highly treatable.

Common Symptoms and “B-Symptoms”

The most common sign of MCL is painless swelling in the lymph nodes—most often in the neck, armpits, or groin ^[1]. However, because the disease can involve many organs, symptoms can vary. Doctors pay close attention to a trio of symptoms known as B-symptoms, which can indicate a more active disease process:

• Fevers: Unexplained temperatures, often occurring daily ^[4].
• Drenching Night Sweats: Sweating so heavily that pajamas or bedsheets need to be changed ^[4].
• Unintended Weight Loss: Losing more than 10% of your body weight over six months without trying ^[4].

Gastrointestinal Involvement and MLP

One of the unique features of MCL is its tendency to involve the gastrointestinal (GI) tract. While only about 15% to 30% of patients have GI symptoms like abdominal pain or bloating at diagnosis, up to 80% or 90% may have microscopic lymphoma cells in their digestive system ^[5].

A specific manifestation of this is Multiple Lymphomatous Polyposis (MLP) ^[6]. In MLP, the lymphoma forms numerous small, pearl-like polyps (growths) along the lining of the stomach or intestines ^[7][5]. Because these polyps and other GI involvements are often invisible on standard CT or PET scans, doctors frequently recommend a colonoscopy and upper endoscopy as part of the initial “workup” or staging process ^[8]. Confirming whether the disease is in the gut helps your care team accurately stage the cancer and plan the most effective treatment.

Differentiating MCL from Other Lymphomas

To the untrained eye, MCL cells can look very similar to other slow-growing cancers like Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). Because the treatments for these diseases are different, getting a definitive diagnosis is vital. Pathologists use a combination of tests to confirm MCL:

• Cyclin D1 & SOX11: Most MCL cells produce an abnormal amount of a protein called Cyclin D1, which is not found in CLL ^[9]. For the rare cases that are Cyclin D1-negative, a marker called SOX11 is used to confirm the diagnosis ^[10].
• FISH Testing: A genetic test called Fluorescence In Situ Hybridization (FISH) is the “gold standard.” It looks for the t(11;14) translocation, a specific genetic “swap” that is the hallmark of Mantle Cell Lymphoma ^[9][9].
• CD200 and CD23: These are proteins found on the surface of cells. They are typically positive in CLL but negative or rare in classic MCL, helping doctors distinguish between the two ^[11].

Read next about Subtypes and Clinical Behavior.